Locoregional treatment for breast carcinoma after Hodgkin's lymphoma: The breast conservation option

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 2, 2012, Pages

  Haberer, Sophie ^a   Belin, Lisa ^a   Le Scodan, Romuald ^a   Kirova, Youlia M ^a   Savignoni, Alexia ^a   Stevens, Denise ^a   Moisson, Patricia ^a   Decaudin, Didier ^a   Pierga, Jean Yves ^a   Reyal, Fabien ^a   Campana, Franois ^a   Fourquet, Alain ^a   Bollet, Marc A ^a  

^a INSTITUT CURIE   (France)

Author keywords

Breast cancer; Breast conserving surgery; Hodgkin's lymphoma; Local recurrence; Radiotherapy

Indexed keywords

ADJUVANT RADIOTHERAPY; BREAST CANCER; BREAST CARCINOMAS; BREAST CONSERVATION; BREAST CONSERVING SURGERY; BREAST RADIOTHERAPY; CONFIDENCE INTERVAL; DECUBITUS; DISEASE FREE SURVIVAL; DUCTAL CARCINOMA IN SITU; HODGKIN'S LYMPHOMA; IN-SITU; INVASIVE TUMORS; LOCAL RECURRENCE; LOCOREGIONAL CONTROL RATE; MEDICAL RECORD; OVERALL SURVIVAL RATES; THORACIC IRRADIATIONS; TOTAL DOSE;

DIAGNOSIS; DISEASES; IRRADIATION; ONCOLOGY; RADIOTHERAPY; SURGERY; TUMORS;

FISH;

ANTHRACYCLINE; AROMATASE INHIBITOR; DOCETAXEL; GONADORELIN AGONIST; PACLITAXEL; TAMOXIFEN; TRASTUZUMAB;

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER GRADING; CANCER GROWTH; CANCER HORMONE THERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HODGKIN DISEASE; HUMAN; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; MANTLE FIELD RADIOTHERAPY; MEDICAL RECORD REVIEW; OVERALL SURVIVAL; PARTIAL MASTECTOMY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; CONFIDENCE INTERVALS; DACARBAZINE; DOXORUBICIN; FEMALE; HODGKIN DISEASE; HUMANS; LYMPH NODE EXCISION; MASTECTOMY, SEGMENTAL; MECHLORETHAMINE; MEDIASTINUM; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; PREDNISONE; PROCARBAZINE; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; VINBLASTINE; VINCRISTINE; YOUNG ADULT;

EID: 84855850733     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.03.013     Document Type: Article

References (49)

1. S. Bhatia, L.L. Robison, and O. Oberlin Breast cancer and other second neoplasms after childhood Hodgkin's disease N Engl J Med 334 1996 745 751
2. P. Nyandoto, T. Muhonen, and H. Joensuu Second cancer among long-term survivors from Hodgkin's disease Int J Radiat Oncol Biol Phys 42 1998 373 378
3. R. Sankila, S. Garwicz, and J.H. Olsen Risk of subsequent malignant neoplasms among 1,641 Hodgkin's disease patients diagnosed in childhood and adolescence: A population-based cohort study in the five Nordic countries. Association of the Nordic Cancer Registries and the Nordic Society of Pediatric Hematology and Oncology J Clin Oncol 14 1996 1442 1446
4. M.L. De Bruin, J. Sparidans, and M.B. van't Veer Breast cancer risk in female survivors of Hodgkin's lymphoma: Lower risk after smaller radiation volumes J Clin Oncol 27 2009 4239 4246
5. T.O. Henderson, A. Amsterdam, and S. Bhatia Systematic review: Surveillance for breast cancer in women treated with chest radiation for childhood, adolescent, or young adult cancer Ann Intern Med 152 2010 444 455 W144-454
6. M.A. Alm El-Din, S.A. El-Badawy, and A.G. Taghian Breast cancer after treatment of Hodgkin's lymphoma: General review Int J Radiat Oncol Biol Phys 72 2008 1291 1297
7. M.A. Alm El-Din, K.S. Hughes, and D.M. Finkelstein Breast cancer after treatment of Hodgkin's lymphoma: Risk factors that really matter Int J Radiat Oncol Biol Phys 73 2009 69 74
8. C.T. Chung, J.A. Bogart, and J.F. Adams Increased risk of breast cancer in splenectomized patients undergoing radiation therapy for Hodgkin's disease Int J Radiat Oncol Biol Phys 37 1997 405 409
9. L.B. Travis, D.A. Hill, and G.M. Dores Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease JAMA 290 2003 465 475
10. I. Meattini, L. Livi, and C. Saieva Breast cancer following Hodgkin's Disease: The experience of the University of Florence Breast J 16 2010 290 296
11. M.A. Alm El-Din, J.K. Feng, and A.G. Taghian Lumpectomy and partial breast irradiation for early-stage breast cancer following mantle irradiation for Hodgkin's lymphoma Nat Clin Pract Oncol 5 2008 426 429
12. I. Aref, and P. Cross Conservative surgery and radiation therapy for early stage breast cancer after previous mantle radiation for Hodgkin's disease Br J Radiol 73 2000 905 906
13. M. Chadha, H. Yoon, and S. Feldman Partial breast brachytherapy as the primary treatment for breast cancer diagnosed after mantle radiation therapy for Hodgkin's disease Am J Clin Oncol 32 2009 132 136
14. M. Intra, O. Gentilini, and P. Veronesi A new option for early breast cancer patients previously irradiated for Hodgkin's disease: Intraoperative radiotherapy with electrons (ELIOT) Breast Cancer Res 7 2005 R828 R832
15. M. Deutsch, K. Gerszten, and W.D. Bloomer Lumpectomy and breast irradiation for breast cancer arising after previous radiotherapy for Hodgkin's disease or lymphoma Am J Clin Oncol 24 2001 33 34
16. B. Cutuli, C. Borel, and F. Dhermain Breast cancer occurred after treatment for Hodgkin's disease: Analysis of 133 cases Radiother Oncol 59 2001 247 255
17. Nguyen SK, Dagnault A. Breast-conserving therapy after previous irradiation for lymphoma. Breast Cancer Res Treat;124:845-849.
18. S.E. Singletary, and F.L. Greene Revision of breast cancer staging: The 6th edition of the TNM Classification Semin Surg Oncol 21 2003 53 59
19. H.S. Kaplan The radical radiotherapy of regionally localized Hodgkin's disease Radiology 78 1962 553 561
20. S.A. Rosenberg, and H.S. Kaplan The evolution and summary results of the Stanford randomized clinical trials of the management of Hodgkin's disease: 1962-1984 Int J Radiat Oncol Biol Phys 11 1985 5 22
21. P. Carde, A. Hagenbeek, and M. Hayat Clinical staging versus laparotomy and combined modality with MOPP versus ABVD in early-stage Hodgkin's disease: The H6 twin randomized trials from the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group J Clin Oncol 11 1993 2258 2272
22. A. Engert, P. Schiller, and A. Josting Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: Results of the HD8 trial of the German Hodgkin's Lymphoma Study Group J Clin Oncol 21 2003 3601 3608
23. R.T. Hoppe, C.N. Coleman, and R.S. Cox The management of stage I-II Hodgkin's disease with irradiation alone or combined modality therapy: The Stanford experience Blood 59 1982 455 465
24. F. Campana, Y.M. Kirova, and J.C. Rosenwald Breast radiotherapy in the lateral decubitus position: A technique to prevent lung and heart irradiation Int J Radiat Oncol Biol Phys 61 2005 1348 1354
25. J. Chavaudra Last ICRU recommendations for the prescription, recording and reporting of external bean therapy [in French] Cancer Radiother 2 1998 607 614
26. A.L. Balaton, J.M. Coindre, and F. Collin Recommendations for the immunohistochemical evaluation of hormone receptors on paraffin sections of breast cancer. Study Group on Hormone Receptors using Immunohistochemistry FNCLCC/AFAQAP. National Federation of Centres to Combat Cancer/French Association for Quality Assurance in Pathology [in French] Ann Pathol 16 1996 144 148
27. A. Vincent-Salomon, G. MacGrogan, and J. Couturier Calibration of immunohistochemistry for assessment of HER2 in breast cancer: Results of the French multicentre GEFPICS study Histopathology 42 2003 337 347
28. T.A. Lister, D. Crowther, and S.B. Sutcliffe Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting J Clin Oncol 7 1989 1630 1636
29. G.M. Dores, C. Metayer, and R.E. Curtis Second malignant neoplasms among long-term survivors of Hodgkin's disease: A population-based evaluation over 25 years J Clin Oncol 20 2002 3484 3494
30. A.K. Ng, M.V. Bernardo, and E. Weller Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: Long-term risks and risk factors Blood 100 2002 1989 1996
31. D.L. Wahner-Roedler, D.F. Nelson, and I.T. Croghan Risk of breast cancer and breast cancer characteristics in women treated with supradiaphragmatic radiation for Hodgkin lymphoma: Mayo Clinic experience Mayo Clin Proc 78 2003 708 715
32. S.L. Wolden, S.L. Hancock, and R.W. Carlson Management of breast cancer after Hodgkin's disease J Clin Oncol 18 2000 765 772
33. L.D. Stegman, K.P. Beal, and M.A. Hunt Long-term clinical outcomes of whole-breast irradiation delivered in the prone position Int J Radiat Oncol Biol Phys 68 2007 73 81
34. S.K. Basu, C. Schwartz, and S.G. Fisher Unilateral and bilateral breast cancer in women surviving pediatric Hodgkin's disease Int J Radiat Oncol Biol Phys 72 2008 34 40
35. B. Cutuli, A. de La Rochefordiere, and F. Dhermain Bilateral breast cancer after Hodgkin disease. Clinical and pathological characteristics and therapeutic possibilities: An analysis of 13 cases [in French] Cancer Radiother 1 1997 300 306
36. M.A. Alm El-Din, K.S. Hughes, and R.A. Raad Clinical outcome of breast cancer occurring after treatment for Hodgkin's lymphoma: Case-control analysis Radiat Oncol 4 2009 19
37. D.D. Gervais-Fagnou, C. Girouard, and N. Laperriere Breast cancer in women following supradiaphragmatic irradiation for Hodgkin's disease Oncology 57 1999 224 231
38. S.L. Wolden, K.R. Lamborn, and S.F. Cleary Second cancers following pediatric Hodgkin's disease J Clin Oncol 16 1998 536 544
39. J. Yahalom Breast cancer after Hodgkin disease: Hope for a safer cure JAMA 290 2003 529 531
40. A.C. Aisenberg, D.M. Finkelstein, and K.P. Doppke High risk of breast carcinoma after irradiation of young women with Hodgkin's disease Cancer 79 1997 1203 1210
41. J. Yahalom, J.A. Petrek, and P.W. Biddinger Breast cancer in patients irradiated for Hodgkin's disease: A clinical and pathologic analysis of 45 events in 37 patients J Clin Oncol 10 1992 1674 1681
42. Broeks A, Braaf LM, Wessels LF, et al. Radiation-associated breast tumors display a distinct gene expression profile. Int J Radiat Oncol Biol Phys;76:540-547.
43. A. Broeks, L.M. Braaf, and A. Huseinovic Identification of women with an increased risk of developing radiation-induced breast cancer: A case only study Breast Cancer Res 9 2007 R26
44. T. Girinsky, L. Specht, and M. Ghalibafian The conundrum of Hodgkin lymphoma nodes: To be or not to be included in the involved node radiation fields. The EORTC-GELA lymphoma group guidelines Radiother Oncol 88 2008 202 210
45. T. Girinsky, R. van der Maazen, and L. Specht Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: Concepts and guidelines Radiother Oncol 79 2006 270 277
46. B.S. Chera, C. Rodriguez, and C.G. Morris Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: Conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy Int J Radiat Oncol Biol Phys 75 2009 1173 1180
47. S.J. Howell, C. Searle, and V. Goode The UK national breast cancer screening programme for survivors of Hodgkin lymphoma detects breast cancer at an early stage Br J Cancer 101 2009 582 588
48. D. Saslow, C. Boetes, and W. Burke American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography CA Cancer J Clin 57 2007 75 89
49. K.C. Oeffinger, J.S. Ford, and C.S. Moskowitz Breast cancer surveillance practices among women previously treated with chest radiation for a childhood cancer JAMA 301 2009 404 414